ClinicalTrials.gg
RecruitingNCT05351229Updated Jun 9, 2026

Intrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery

A Phase 4 interventional study of Morphine Sulfate and Placebo in Pain, Postoperative, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-09.

Sponsored by Northwestern University · Phase 4, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Sep 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 97 studies testing morphine in Pain, Postoperative — 18 open to participants now, 21 under way, 1 of them phase 3. Morphine · Pain, Postoperative.

Planned enrollment
42nd of 97
90 · median 90
Started
2023
with 3 others
Phase 4
42 of 97
7 open now
Primary completion
2027-06
later than 14 of 20 live
Registered
70th of 97
by date
Lead sponsor
3 of 97
Northwestern University

Among the 97 studies testing morphine in Pain, Postoperative, this one is the 42nd largest by planned enrollment, is one of 4 that started in 2023, is one of 42 in phase 4, reaches primary completion later than 14 of the 20 other live ones, and was the 70th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

18 of the 97 studies testing morphine in Pain, Postoperative are open now, in 11 countries. Recruiting first, the newest first:

12 more — sign in →

By country, each count listing its studies:

All 18 open studies →

About morphine

Morphine: first FDA approval 1984 (DURAMORPH PF). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 97 studies testing morphine in Pain, Postoperative, or all of them as a file.
02

Study summary

VATS/RATS is widely used for diagnosis and treatment of intrathoracic conditions. Despite many benefits, postoperative pain continues to be intense after VATS/RATS. The optimal strategy for pain management has not been defined. In this randomized, placebo-controlled, double-blinded clinical investigation, investigators hypothesize that 5 mcg/kg intrathecal morphine will decrease postoperative analgesic consumption and reduce pain.

Read the detailed description

This is a randomized, placebo-controlled, double-blinded clinical trial. Patients will be randomized into one of two groups. Group A (Placebo, control group) will receive intrathecal sterile normal saline and Group B (Morphine group) will receive 5mcg/kg preservative free intrathecal morphine.

American Pain Society Outcome Questionnaire (APS-POQ) will be administered to patients prior to discharge (see data sheet).

Patients will be followed up with a phone survey at 1 and 3 months after surgery to assess the presence, nature, and severity of chronic persistent surgical pain. The Brief Pain Inventory is a reliable and valid measures of the interference of pain with physical functioning and will be used. Additionally patients will be asked about use of pain medications

03

Conditions studied

  • Pain, Postoperative

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-80 years old
  • Undergoing elective video-assisted thoracoscopic or robotic assisted surgery for anatomical lung resection
  • General anesthesia with anticipated intraoperative extubation.

Exclusion criteria

Exclusion Criteria:

  • (ASA) classification of 4 or 5
  • Anticipated postoperative intubation
  • Significant liver disease
  • Preoperative use of intravenous inotropes and/or vasopressor support
  • Preoperative mechanical ventilation
  • Preoperative use of mechanical circulatory support device (intraaortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation)
  • Severe pulmonary disease (home oxygen requirement and/or current oral use)
  • Morphine allergy
  • Opioid or alcohol abuse
  • Chronic pain
  • Renal failure
  • Inability to comprehend English language
  • Bleeding disorder
  • Abnormal preoperative coagulation
  • Infection
  • Patient refusal
  • Failed spinal
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Placebo comparator
    Placebo

    Placebo, Intrathecal saline

    Other: Placebo

  • Active comparator
    Morphine

    Intrathecal morphine

    Drug: Morphine Sulfate

Interventions

  • DrugMorphineStudies of MorphineMorphine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    5 mcg/kg intrathecal preservative free morphine sulfate

  • OtherPlacebo

    Sterile saline, placebo

    Also known as: Sterile Saline

06

What researchers measure

Primary outcomes

  1. Postoperative morphine equivalent consumption

    Total MG of analgesic medications given converted to morphine

    Time frame: 24 hours after surgery

Secondary outcomes

  1. Postoperative pain

    Visual analog score between 0-10

    Time frame: Up to 48 hours postoperative

  2. Number of pain interventions

    Number of times patient given medication for pain

    Time frame: up to 48 hours postoperative

  3. Postoperative opioid related side effects

    Nausea medication administration, airway events, urinary retention, pruritus medication given,

    Time frame: up to 48 hours postoperative

  4. Self-reported patient satisfaction

    American Pain Society Outcome Questionnaire

    Time frame: prior to discharge from hospital, likely 1-3 days after surgery

  5. pain qualities

    pain intensity, location, quality via Brief Pain Inventory

    Time frame: 1 month and 3 months after surgery

  6. Self reported use of analgesic medications

    Questions asked via phone call at 1 month and 3 months.

    Time frame: 1 month and 3 months after surgery

  7. self-reported limitation of daily activity at 1 and 3 months

    Questions asked via phone call at 1 month and 3 months

    Time frame: 1 month and 3 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Not necessary to conduct study or data analysis

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Jun 2027, 44 months after the start.

Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 44 months is above that.

Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2022
First posted
Apr 28, 2022
StartActual
Sep 29, 2023
Primary completionEst.
Jun 1, 2027
CompletionEst.
Sep 1, 2027
Last update
Jun 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05351229
Responsible party
Richa Dhawan (Associate Professor, Northwestern University) — Principal investigator
First posted
Apr 28, 2022
Start date
Sep 29, 2023
Primary completion
Jun 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Jun 9, 2026

Study contacts

Richa Dhawan, MD MPH
Contact
richa.dhawan@northwestern.edu
312-695-0061

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Morphine

Start the discussion